Kampanjeplan Allogene Therapeutics
Avansert tidsplan
Enkel graf
Om selskapet Allogene Therapeutics
Allogene Therapeutics, Inc., иммуноонкологическая компания клинической стадии, занимается исследованиями, разработкой и коммерциализацией генно-инженерных методов лечения аллогенными Т-клетками для лечения рака. Компания была основана в 2017 году, ее штаб-квартира находится в Южном Сан-Франциско, Калифорния.IPO date | 2018-10-11 |
---|---|
ISIN | US0197701065 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.allogene.com |
Цена ао | 2.06 |
Prisendring per dag: | 0% (2.06) |
---|---|
Prisendring per uke: | +1.98% (2.02) |
Prisendring per måned: | +47.14% (1.4) |
Prisendring over 3 måneder: | +1.98% (2.02) |
Prisendring over seks måneder: | -30.41% (2.96) |
Prisendring per år: | -54.17% (4.495) |
Prisendring over 3 år: | -72.68% (7.54) |
Prisendring over 5 år: | -92.41% (27.14) |
Prisendring over 10 år: | 0% (2.06) |
Prisendring siden begynnelsen av året: | +5.64% (1.95) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
FMR, LLC | 25241499 | 14.93 |
TPG GP A, LLC | 18716306 | 11.07 |
Blackrock Inc. | 10001804 | 5.92 |
Vanguard Group Inc | 9030825 | 5.34 |
JP Morgan Chase & Company | 6906761 | 4.08 |
PRIMECAP Management Company | 5281886 | 3.12 |
Citadel Advisors Llc | 4053226 | 2.4 |
Goldman Sachs Group Inc | 3337214 | 1.97 |
Woodline Partners LP | 2577500 | 1.52 |
State Street Corporation | 2427284 | 1.44 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. David D. Chang M.D., Ph.D. | Co-Founder, President, CEO & Director | 1.1M | 1960 (65 år) |
Mr. Joshua A. Kazam | Co-Founder & Director | 711k | 1977 (48 år) |
Ms. Christine Cassiano | Executive VP, Chief Corporate Affairs & Brand Strategy Officer | N/A | |
Ms. Susan R. Lundeen | Chief People Officer | N/A | 1966 (59 år) |
Mr. Timothy L. Moore Ph.D. | Executive VP & Chief Technical Officer | N/A | 1961 (64 år) |
Mr. Earl M. Douglas Esq. | Senior VP, General Counsel, Compliance Officer & Corporate Secretary | N/A | 1963 (62 år) |
Dr. Arie S. Belldegrun F.A.C.S., M.D. | Co-Founder & Executive Chairman | 714.25k | 1949 (76 år) |
Dr. Zachary J. Roberts M.D., Ph.D. | Executive VP of Research & Development and Chief Medical Officer | N/A | 1978 (47 år) |
Mr. Geoffrey M. Parker | Executive VP & CFO | 1965 (60 år) | |
Ms. Annie Yoshiyama | Senior VP, Corporate Controller & Principal Accounting Officer | 1984 (41 år) |
Adresse: United States, South San Francisco, CA , 210 East Grand Avenue - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.allogene.com
Nettsted: http://www.allogene.com